For the first time on PodcastRx, we're (finally) addressing some listener feedback! One of Chris's correctional provider contacts wanted to hear a show devoted to "all things heartburn and gastric reflux", and we were more than happy to oblige.

For the main discussion, Chris covers the differences among treatment classes for heartburn and reflux medications, the latest treatment guidelines, whether proton pump inhibitors deserve a bad reputation, concerns about antacid overuse, and non-pharmacologic considerations.

Before that, Chris shares a few updates related to

-New motion sickness drug approval

-Updated refractory constipation guidelines

-Upadacitinib vs. adalimumab trial for rheumatoid arthritis

-Treating scabies with ivermectin vs. permethrin

-Bismuth quadruple therapy for H. pylori